Ukr.Biochem.J. 2013; Volume 85, Issue 3, May-Jun, pp. 90-95


Cholecalciferol hydroxylation in rat hepatocytes under the influence of prednisolone

A. V. Khomenko

Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;

Glucocorticoid therapy is accompanied by development of processes typical of steroid osteoporosis. Indirect effects of glucocorticoids on the bone tissue are due to changes in mineral metabolism, which is regulated by vitamin D3. In this connection, we studied the influence of prednisolone on cholecalciferol metabolism. The study has shown that prednisolone action causes impairment of cholecalciferol metabolism in hepatocytes due to inhibiting vitamin D3 25-hydroxylase activity. Microsomal (CYP2R1) and mitochondrial (CYP27A1­) isoenzymes of vitamin D3 25-hydroxylase were found to function at different concentrations of the substrate. The relative protein contents of the isoenzymes greatly differed in the liver with the prevalence of CYP27A1 over CYP2R1. Prednisolone administration resulted in the lowering of both mitochondrial and microsomal isoenzymes of vitamin D3 25-hydroxylase. The inhibition of vitamin D3 25-hydroxylating system in hepatocytes contributed to a significant reduction in blood serum 25OHD3.

Keywords: , , , , , , ,


  1. Gordon MM, Stevenson S, Hunter JA. Steroids cause osteoporosis. Ann Rheum Dis. 2002 Oct;61(10):947; author reply 947-8. PubMed, PubMedCentral, CrossRef
  2. Gulko PS, Mulloy AL. Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment. Clin Exp Rheumatol. 1996 Mar-Apr;14(2):199-206. Review. PubMed
  3. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4-8. Review. PubMed
  4. Gayko GV, Kalashnikov AV, Brusko AT Vitamin D and bone system. K.: Kniga Plius, 2008. 176p.
  5. Bikle D. Nonclassic Actions of Vitamin D. J Clin Endocrinol Metab. 2009 Jan; 94(1): 26-34.  PubMedPubMedCentralCrossRef
  6. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr. 2008 Apr;87(4):1087S-91S. Review. PubMed
  7. Jones G. Standardy Medyczne. Pediatria. 2012;5:605-609.
  8. Holick MF. To screen or not to screen for 25-hydroxyvitamin D: that is the D-lemma. Standardy Med Pediatria. 2012;5:590-594.
  9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248-54. PubMed
  10. Apukhovskaia LI, Khrestovaia NL, Antonenko LV. Metabolism of vitamin D3 administered in liposomes in rat liver. Ukr Biokhim Zhurn. 1991 Sep-Oct;63(5):89-94. Russian. PubMed
  11. Paulson SK, Phelps M, DeLuca HF. Assay and properties of rat yolk sac 25-hydroxyvitamin D3 1 alpha-hydroxylase. Biochemistry. 1986 Nov 4;25(22):6821-6. PubMed, CrossRef
  12. Quistorff B, Dich J, Grunnet N. Preparation of isolated rat liver hepatocytes. Methods Mol Biol. 1990;5:151-60. PubMed, CrossRef
  13. Velykyi MM, Apukhovska LI, Khomenko AV, Shymanskyi IO, Vasylevska VM, Lototska OYu, Bezusiak AI, Makarova OO. Features of hypocalcemic action of prednisolone at different availability of rats with vitamin D3. Med Chem. 2011;13(3(48):5-12.
  14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680-5. PubMedCrossRef
  15. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004 Dec;29(12):664-73. Review. PubMed, CrossRef
  16. Gaston-Barre M. / In: Vitamin D, ed. by  Feldman D., Elsevir, 2005. P. 47–67.
  17. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem. 2003 Sep 26;278(39):38084-93. PubMed, PubMedCentral, CrossRef
  18. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1689S-96S. Review. PubMed
  19. Zhu J, DeLuca HF. Vitamin D 25-hydroxylase – Four decades of searching, are we there yet? Arch Biochem Biophys. 2012 Jul 1;523(1):30-6. Review. PubMed
  20. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA. 2004 May 18;101(20):7711-5. PubMed, PubMedCentral, CrossRef
  21.  Sakaki T. Recent studies on vitamin D metabolizing enzymes. Clin Calcium. 2006 Jul;16(7):1129-35. Review. Japanese. PubMed
  22. Berginer VM, Shany S, Alkalay D, Berginer J, Dekel S, Salen G, Tint GS, Gazit D. Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism. 1993 Jan;42(1):69-74. PubMed, CrossRef
  23.  Shinkyo R, Sakaki T, Kamakura M, Ohta M, Inouye K. Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun. 2004 Nov 5;324(1):451-7. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.